Skip to main content

1 Result(s)

within Ya-nan Huo Remove this filter Endocrinology Remove this filter Orthopedics Remove this filter

and

  1. Article

    Open Access

    Efficacy of Yigu® versus Aclasta® in Chinese postmenopausal women with osteoporosis: a multicenter prospective study

    Zoledronic acid (ZOL) is a therapy inhibiting bone resorption. In this study, generic ZOL (Yigu®) showed its clinical efficacy consistency with original ZOL (Aclasta®) in Chinese postmenopausal women with oste...

    Mei Li, Qun Cheng, Ya-nan Huo, Ai-jun Chao, Liang He… in Archives of Osteoporosis (2022)

    Download PDF (1059 KB) View Article